Osteoprotegerin (OPG) human

INQUIRY Add to cart

For Research Use Only | Not For Clinical Use

CAT

IAR42413746

Description	recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), suitable for cell culture
Assay	≥98% (HPLC); ≥98% (SDS-PAGE)
Color	white to off-white
Form	lyophilized
Impurity Content	<0.1 EU/μg endotoxin, tested
Size	50μG
Storage Conditions	−20°C

Expression of the RANK/RANKL/OPG System in the Human Intervertebral Disc: Implication for the Pathogenesis of Intervertebral Disc Degeneration

Tomohiko Sano, Koji Akeda, Junichi Yamada, Norihiko Takegami, Takao Sudo, Akihiro Sudo

BMC Musculoskelet Disord. 2019 May 17;20(1):225.

PMID: 31101043

RANK/RANKL/OPG System in the Intervertebral Disc

Norihiko Takegami, Koji Akeda, Junichi Yamada, Tomohiko Sano, Koichiro Murata, Jenny Huang, Koichi Masuda, Akihiro Sudo

Arthritis Res Ther. 2017 Jun 2;19(1):121.

PMID: 28576140

RANKL/RANK/OPG System Beyond Bone Remodeling: Involvement in Breast Cancer and Clinical Perspectives

Marco Infante, Alessandra Fabi, Francesco Cognetti, Stefania Gorini, Massimiliano Caprio, Andrea Fabbri

J Exp Clin Cancer Res. 2019 Jan 8;38(1):12.

PMID: 30621730

Receptor Activator of Nuclear factor-κB Ligand (RANKL)/RANK/osteoprotegerin System in Bone and Other Tissues (Review)

Wei Liu, Xianlong Zhang

Mol Med Rep. 2015 May;11(5):3212-8.

PMID: 25572286

The Bone Remodelling Cycle

J S Kenkre, Jhd Bassett

Ann Clin Biochem. 2018 May;55(3):308-327.

PMID: 29368538

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.

Online Inquiry